IDEXX Laboratories Statistics Share Statistics IDEXX Laboratories has 80M
shares outstanding. The number of shares has increased by -2.29%
in one year.
Shares Outstanding 80M Shares Change (YoY) -2.29% Shares Change (QoQ) -0.76% Owned by Institutions (%) 90.48% Shares Floating 79.21M Failed to Deliver (FTD) Shares 16 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 2.64M, so 3.26% of the outstanding
shares have been sold short.
Short Interest 2.64M Short % of Shares Out 3.26% Short % of Float 4.26% Short Ratio (days to cover) 6.56
Valuation Ratios The PE ratio is 38.4 and the forward
PE ratio is 46.75.
IDEXX Laboratories's PEG ratio is
6.51.
PE Ratio 38.4 Forward PE 46.75 PS Ratio 8.75 Forward PS 11.4 PB Ratio 21.37 P/FCF Ratio 42.72 PEG Ratio 6.51
Financial Ratio History Enterprise Valuation IDEXX Laboratories has an Enterprise Value (EV) of 34.79B.
EV / Sales 8.93 EV / EBITDA 27.27 EV / EBIT 37.45 EV / FCF 43.6
Financial Position The company has a current ratio of 1.31,
with a Debt / Equity ratio of 0.62.
Current Ratio 1.31 Quick Ratio 0.95 Debt / Equity 0.62 Debt / EBITDA 0.77 Debt / FCF 1.24 Interest Coverage 36.16
Financial Efficiency Return on Equity is 55.65% and Return on Invested Capital is 33.87%.
Return on Equity 55.65% Return on Assets 26.96% Return on Invested Capital 33.87% Revenue Per Employee $354.32K Profits Per Employee $80.72K Employee Count 11,000 Asset Turnover 1.18 Inventory Turnover 3.98
Taxes Income Tax 221.96M Effective Tax Rate 20%
Stock Price Statistics The stock price has increased by 35.94% in the
last 52 weeks. The beta is 1.5, so IDEXX Laboratories's
price volatility has been higher than the market average.
Beta 1.5 52-Week Price Change 35.94% 50-Day Moving Average 544.5 200-Day Moving Average 464.08 Relative Strength Index (RSI) 67.59 Average Volume (20 Days) 607,890
Income Statement In the last 12 months, IDEXX Laboratories had revenue of 3.9B
and earned 887.87M
in profits. Earnings per share was 10.77.
Revenue 3.9B Gross Profit 2.38B Operating Income 1.13B Net Income 887.87M EBITDA 1.28B EBIT 1.14B Earnings Per Share (EPS) 10.77
Full Income Statement Balance Sheet The company has 288.27M in cash and 986.95M in
debt, giving a net cash position of -698.68M.
Cash & Cash Equivalents 288.27M Total Debt 986.95M Net Cash -698.68M Retained Earnings 5.33B Total Assets 3.33B Working Capital 138.48M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 929M
and capital expenditures -130.92M, giving a free cash flow of 798.08M.
Operating Cash Flow 929M Capital Expenditures -130.92M Free Cash Flow 798.08M FCF Per Share 9.68
Full Cash Flow Statement Margins Gross margin is 61.04%, with operating and profit margins of 28.95% and 22.78%.
Gross Margin 61.04% Operating Margin 28.95% Pretax Margin 28.48% Profit Margin 22.78% EBITDA Margin 32.73% EBIT Margin 28.95% FCF Margin 20.48%
Dividends & Yields IDXX does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield 2.6% FCF Yield 2.34%
Dividend Details Analyst Forecast The average price target for IDXX is $558,
which is -14.5% lower than the current price. The consensus rating is "Buy".
Price Target $558 Price Target Difference -14.5% Analyst Consensus Buy Analyst Count 7
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $103.07 Lynch Upside -84.2% Graham Number 68.46 Graham Upside -89.51%
Stock Splits The last stock split was on Jun 16, 2015. It was a
forward
split with a ratio of 2:1.
Last Split Date Jun 16, 2015 Split Type forward Split Ratio 2:1
Scores Altman Z-Score 21.56 Piotroski F-Score 7
